Nomura has initiated coverage on Anthem Biosciences with a Buy rating and a ₹740 target, citing attractive valuations, strong CRDMO positioning, diversified capabilities, and robust revenue and earnings growth projections despite recent stock correction.Read More
A 72-year-old Mumbai resident, Bharat Harakchand Shah, has filed a police complaint after discovering that his inherited equity portfolio—long believed to be growing—had allegedly been mismanaged, leading to a sudden demand for ₹35 crore. The case is now under investigation by Mumbai Police’s Economic Offences Wing, with an FIR filed against Globe Capital.Read More
Aequs Limited’s Rs 921.81-crore IPO opens on December 3 with strong grey-market interest, trading at a 21% premium over the upper price band of Rs 124. The issue includes a fresh offer and OFS, with listing expected on December 10. Pre-IPO participation by major funds signals solid institutional demand.Read More
Meesho’s upcoming IPO highlights the rise of India’s digital economy, driven by small towns. The company built its success by empowering micro-entrepreneurs and resellers, offering affordable products to a digitally connected ‘Bharat’. This strategy has fueled rapid growth, making it a significant player beyond metropolitan markets.Read More
Japan’s Nikkei 225 closed up 0.2% on Friday, extending its weekly gain despite a challenging November. Investor focus is shifting to upcoming central bank decisions, with Tokyo’s core inflation hinting at a potential Bank of Japan rate hike. U.S. tech stocks’ performance hinges on the Federal Reserve’s December interest rate outlook.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
